GenHunter Corporation was founded in 1992, the year the technique was invented, by Dr. Peng Liang, the co-inventor of the differential display technology, to provide the biomedical research community easy access to the technology. Since 1992, GenHunter Corporation has continued to improve, perfect and streamline the technology. Our complete line of innovative products centered around differential display technology has made GenHunter synonymous with differential display. GenHunter Corporation has been the exclusive licensee for the manufacturing and marketing of differential display reagent business. Our intensive research and development, highest quality assurance, and expert technical support has established GenHunter as the world leader in differential display technology.

In the short period of time since it's invention, differential display has become the most widely used methodology to clone differentially expressed genes. In fact, the number of publications using differential display has far exceeded the number of publications using all the other competitive methods combined. Despite of the recent interest in DNA microarry, there have been over 1200 scientists who have published the successful cloning of differentially expressed genes using DD compared with less than 150 publications using DNA microarray, most of which have come from the labs and companies who are developing the technique. GenHunter Corporation is proud to have been the driving force in making this powerful technology within easy reach of biomedical researchers throughout the world.

In addition to our differential display line, our recently acquired AP-TAG™ ligand/receptor interaction detection technology has revolutionized the way cell surface receptors and ligands are detected and cloned. This technology may allow one to further functionally characterize secreted proteins or cell surface molecules cloned by DD or other methods. We carry a complete line of products centered around this revolutionary approach to receptor/ligand studies.